Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.444
+0.006 (1.32%)
At close: Apr 28, 2026, 4:00 PM EDT
0.439
-0.004 (-0.99%)
Pre-market: Apr 29, 2026, 7:00 AM EDT

Silo Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-4.23-4.39-3.7-3.913.9
Upgrade
Depreciation & Amortization
0.010.01---
Upgrade
Loss (Gain) From Sale of Investments
-0000.44-6.91
Upgrade
Stock-Based Compensation
0.64-0.10.070.19
Upgrade
Provision & Write-off of Bad Debts
----0.02-0.15
Upgrade
Other Operating Activities
0.1----0.02
Upgrade
Change in Accounts Payable
-0.990.630.34-0.050.29
Upgrade
Change in Unearned Revenue
-0.07-0.07-0.07-0.070.48
Upgrade
Change in Other Net Operating Assets
-0.12-0.010.030.05-0.04
Upgrade
Operating Cash Flow
-4.66-3.83-3.22-3.5-2.28
Upgrade
Investment in Securities
1.220.97-4.150.077.02
Upgrade
Other Investing Activities
-0.57--0.020.17
Upgrade
Investing Cash Flow
0.640.97-4.150.097.19
Upgrade
Short-Term Debt Issued
----0
Upgrade
Total Debt Issued
----0
Upgrade
Short-Term Debt Repaid
-----0
Upgrade
Total Debt Repaid
-----0
Upgrade
Issuance of Common Stock
4.863.41-4.94-
Upgrade
Repurchase of Common Stock
--0.17-0.47--
Upgrade
Other Financing Activities
-----0.48
Upgrade
Financing Cash Flow
4.863.24-0.474.943.79
Upgrade
Net Cash Flow
0.840.38-7.841.538.71
Upgrade
Cash Interest Paid
0.040.0100-
Upgrade
Cash Income Tax Paid
---0.03-
Upgrade
Levered Free Cash Flow
-3.56-2.07-1.78-2.24-1.1
Upgrade
Unlevered Free Cash Flow
-3.53-2.07-1.78-2.23-1.1
Upgrade
Change in Working Capital
-1.180.550.3-0.080.73
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.